Best of the Week
Most Popular
1. Stock Markets and the History Chart of the End of the World (With Presidential Cycles) - 28th Aug 20
2.Google, Apple, Amazon, Facebook... AI Tech Stocks Buying Levels and Valuations Q3 2020 - 31st Aug 20
3.The Inflation Mega-trend is Going Hyper! - 11th Sep 20
4.Is this the End of Capitalism? - 13th Sep 20
5.What's Driving Gold, Silver and What's Next? - 3rd Sep 20
6.QE4EVER! - 9th Sep 20
7.Gold Price Trend Forecast Analysis - Part1 - 7th Sep 20
8.The Fed May “Cause” The Next Stock Market Crash - 3rd Sep 20
9.Bitcoin Price Crash - You Will be Suprised What Happens Next - 7th Sep 20
10.NVIDIA Stock Price Soars on RTX 3000 Cornering the GPU Market for next 2 years! - 3rd Sep 20
Last 7 days
Gold & Silver Begin New Advancing Cycle Phase - 6th May 21
Vaccine Economic Boom and Bust - 6th May 21
USDX, Gold Miners: The Lion and the Jackals - 6th May 21
What If You Turn Off Your PC During Windows Update? Stuck on Automatic Repair Nightmare! - 6th May 21
4 Insurance Policies You Should Consider Buying - 6th May 21
Fed Taper Smoke and Mirrors - 5th May 21
Global Economic Recovery 2021 and the Dark Legacies of Smoot-Hawley - 5th May 21
Utility Stocks Continue To Rally – Sending A Warning Signal Yet? - 5th May 21
ROIMAX Trading Platform Review - 5th May 21
Gas and Electricity Price Trends so far in 2021 for the United Kingdom - 5th May 21
Crypto Bubble Mania Free Money GPU Mining With NiceHash Continues... - 4th May 21
Stock Market SPX Short-term Correction - 4th May 21
Gold & Silver Wait Their Turn to Ride the Inflationary Wave - 4th May 21
Gold Can’t Wait to Fall – Even Without USDX’s Help - 4th May 21
Stock Market Investor Psychology: Here are 2 Rare Traits Now on Display - 4th May 21
Sheffield Peoples Referendum May 6th Local Elections 2021 - Vote for Committee Decision's or Dictatorship - 4th May 21
AlphaLive Brings Out Latest Trading App for Android - 4th May 21
India Covid-19 Apocalypse Heralds Catastrophe for Pakistan & Bangladesh, Covid in Italy August 2019! - 3rd May 21
Why Ryzen PBO Overclock is Better than ALL Core Under Volting - 5950x, 5900x, 5800x, 5600x Despite Benchmarks - 3rd May 21
MMT: Medieval Monetary Theory - 3rd May 21
Magical Flowering Budgies Bird of Paradise Indoor Grape Vine Flying Fun in VR 3D 180 UK - 3rd May 21
Last Chance to GET FREE Money Crypto Mining with Your Desktop PC - 2nd May 21
Will Powell Lull Gold Bulls to Sweet Sleep? - 2nd May 21
Stock Market Enough Consolidation Already! - 2nd May 21
Inflation or Deflation? (Not a silly question…) - 2nd May 21
What Are The Requirements For Applying For A Payday Loan Online? - 2nd May 21
How to Invest in HIGH RISK Tech Stocks for 2021 and Beyond - Part1 - 1st May 21
INDIA COVID APOCALYPSE - 1st May 21
Are Technicals Pointing to New Gold Price Rally? - 1st May 21
US Dollar Index: Subtle Changes, Remarkable Outcomes - 1st May 21
Stock Market Correction Time Window - 30th Apr 21
Stock Market "Fastest Jump Since 2007": How Leveraged Investors are Courting "Doom" - 30th Apr 21
Three Reasons Why Waiting for "Cheaper Silver" Doesn't Make Cents - 30th Apr 21
Want To Invest In US Real Estate Market But Don’t Have The Down Payment? - 30th Apr 21
King Zuckerberg Tech Companies to Set up their own Governments! - 29th Apr 21
Silver Price Enters Acceleration Phase - 29th Apr 21
Financial Stocks Sector Appears Ready To Run Higher - 29th Apr 21
Stock Market Leverage Reaches New All-Time Highs As The Excess Phase Rally Continues - 29th Apr 21
Get Ready for the Fourth U.S. Central Bank - 29th Apr 21
Gold Mining Stock: Were Upswings Just an Exhausting Sprint? - 29th Apr 21
AI Tech Stocks Lead the Bull Market Charge - 28th Apr 21
AMD Ryzen Overclocking Guide - 5900x, 5950x, 5600x PPT, TDC, EDC, How to Best Settings Beyond PBO - 28th Apr 21
Stocks Bear Market / Crash Indicator - 28th Apr 21
No Upsetting the Apple Cart in Stocks or Gold - 28th Apr 21
Is The Covaids Insanity Actually Getting Worse? - 28th Apr 21
Dogecoin to the Moon! The Signs are Everywhere, but few will Heed them - 28th Apr 21
SPX Indicators Flashing Stock Market Caution - 28th Apr 21
Gold Prices – Don’t Get Too Excited - 28th Apr 21
6 Challenges Contract Managers Face When Handling Contractual Agreements - 28th Apr 21

Market Oracle FREE Newsletter

Category: BioTech

The analysis published under this category are as follows.

Companies

Wednesday, January 20, 2021

The Biggest Biotech Story Of 2021? / Companies / BioTech

By: OilPrice_Com

...

 


Companies

Tuesday, December 29, 2020

Johnson & Johnson Biotech AI Stocks / Companies / BioTech

By: Nadeem_Walayat

This is a continuation of my in-depth analysis into the buying levels for the Top 10 AI stocks to ride the electron mega-trend the whole of which was first made available to Patrons who support my work so immediate first access to ALL of my analysis and trend forecasts then do consider becoming a Patron by supporting my work for just $3 per month.

  • US Presidential Election 2020 Forecast Review
  • Seeing Stock Market New Highs Through the Prism of AI
  • Stock Market Dow Quick Take
  • AI Stocks Buying Levels and EC ratio Explained
  • Top 10 AI Stocks individual analysis i.e. for Google, Amazon, Apple etc.
  • AI Stocks Buying Levels Q4 2020
  • The Next IMMINENT Global Catastrophe After Coronavirus

5. Johnson & Johnson $146

Read full article... Read full article...

 


Companies

Wednesday, December 16, 2020

SILO Stock The Most Undervalued Play In Psychedelic / Companies / BioTech

By: Joshua_Rodriguez

Psychedelics has become a hot topic among the investing community. They’ve been around for some time, and for the most part, these party favors found in dorm rooms are looked at in a negative connotation.

But what if I told you that psychedelics could be the answer to some of the most difficult-to-treat medical conditions.

I know it sounds strange, but oftentimes, there’s therapeutic benefit found in the strangest things, and believe it or not, psychedelics have been used as a medicine for hundreds of years.

No, you’re not going to go to the doctor with a flu and be prescribed psilocybin or LSD, but medicine men among various cultures, including Native Americans, have used these mind-altering compounds as an option for the treatment of various ailments. So, psychedelics as a medicine aren’t anything new.

Today, there are a handful of biotech companies looking to take our understanding of how psychedelics can improve things like cognition in Alzheimer’s and Parkinson’s disease patients, frame of thought in depression patients, and ability to live a relatively normal life in PTSD patients.

Read full article... Read full article...

 


Companies

Friday, December 04, 2020

A new “miracle compound” is set to take over the biotech market / Companies / BioTech

By: Submissions

...

 


Companies

Thursday, December 03, 2020

Early Investors set to win big as FDA fast-tracks this ancient medicine / Companies / BioTech

By: Submissions

...

 


Companies

Wednesday, December 02, 2020

How An Ancient Medicine Is Taking On The $16 Trillion Pharmaceutical Industry / Companies / BioTech

By: Submissions

...

 


Companies

Tuesday, December 01, 2020

The No.1 Biotech Stock for 2021 / Companies / BioTech

By: Submissions

...

 


Companies

Monday, November 30, 2020

Ancient Aztec Secret Could Lead To A $6.9 Billion Biotech Breakthrough / Companies / BioTech

By: Submissions

...

 


Companies

Monday, September 14, 2020

Why Bill Gates Is Betting Millions on Synthetic Biology / Companies / BioTech

By: John_Mauldin

By Justin Spittler: Beyond Meat (BYND) was one of last year’s hottest stocks. Shares of the plant-based meat company exploded 859% during its first three months out of the gate.

“Fake meat” was all the rage: an instant favorite with Millennials (I personally prefer the real thing). And the industry’s still booming today. It’s already worth $12 billion. By 2025, it’s projected to double again!

But here’s the thing: While most people have heard of Beyond Meat and the plant-based meat mania by now, they don’t realize that this is all part of a much bigger opportunity. In fact, many of the wealthiest investors on the planet have been going “all in” on this obscure megatrend.

Read full article... Read full article...

 


Companies

Monday, May 04, 2020

The Biotech Boom May Have Only Just Begun / Companies / BioTech

By: Submissions

“The world is moving so fast these days that the man who says it can't be done is generally interrupted by someone doing it.” ― Elbert Hubbard

A new medical development is sweeping the country…

Some may see it as controversial - but the studies don’t lie.

It’s effective.

So effective, in fact, that the FDA has just fast-tracked approval for research…

Meaning that it is aiming to gain a major stake in a key healthcare market that is on track to hit $260 billion in the next six years.

Read full article... Read full article...

 


Saturday, February 15, 2020

iShares Nasdaq Biotechnology ETF IBB AI Mega-trend Tech Stocks Investing 2020 / / BioTech

By: Nadeem_Walayat

The juggernaut that is Artificial Intelligence continues to rumble along towards an inexorable future, one that most still fail to grasp the magnitude of the changes that are just around the corner as humans think in linear terms whilst the AI trend is EXPONENTIAL. Where developments that even the proponents of AI thought would take several years are taking place in mere MONTHS! That is the power of the unfolding AI MEGA-TREND!

AI has already CHANGED THE WORLD! EXPONENTIALLY! You have an AI super computer right in your pocket for likely less than £1000!

Especially, when one marries AI with other big world changing tech mega-trend "Quantum Computing"! Put the 2 together and we are literally going to see an explosion in SUPER INTELLGENCE that would soon far exceed that of human intelligence, following which it won't be that many years before the AI exceeds the intelligence of the sum of ALL humans! For better or worse, that's the path we are on.

And all those who say AI can be controlled are going to be proven wrong, as new technologies tend to be first sequestered towards military aims. So whilst we focus on the benefits of AI in reality AI is a POWERFUL WEAPON and so the world is in an AI arms race, commercial, economic and military AI arms race.

Read full article... Read full article...

 


Companies

Wednesday, August 28, 2019

Highly Undervalued Biotechnology Stocks To Watch / Companies / BioTech

By: Joshua_Rodriguez

The biotechnology industry is an exciting one. As continued innovation drives a better scientific understanding of the human body and the ailments that weigh on it, we are seeing better outcomes for patients who are living longer, more fulfilling lives.

However, it’s not only the patients that are seeing tremendous benefit out of this innovation. Investors are benefiting greatly as well. After all, as new medications hit the market, tremendous revenue opportunities are being created for the companies creating these treatments.
Read full article... Read full article...

 


Companies

Saturday, July 27, 2019

Human Life Extension Investing in IBB - iShares Nasdaq Biotechnology ETF - IBB / Companies / BioTech

By: Nadeem_Walayat

We are currently galloping full speed along an exponential curve that unlike the neural nets of the 1990's, that promised a lot but delivered very little, this time it really looks like we are on the verge of AI success, not only that but it heralds changes in every aspect of our lives most of which we cannot even imagine today, hence the term the singularity is often used, the AI event horizon beyond which we cannot see.

My latest analysis in this series focuses on how to profit and capitalise on the unfolding machine intelligence driven mega-trend through investing in leveraged to AI Human Life Extension stocks.

Read full article... Read full article...

 


Companies

Thursday, July 18, 2019

Biotech Stocks With Near Term Catalysts / Companies / BioTech

By: Joshua_Rodriguez

Medical innovation is an incredible thing. In fact, as we continue to better understand the human body and cutting-edge biotechnology companies continue to produce innovative medicines, the average life expectancy in human beings is growing at a rate of about two months every year.

Not only is this innovation in medicine leading to a better quality of life and longer lifespan for countless patients, it is also leading strong investment opportunities. Driven by the fact that there are multiple catalysts along the process of drug development and incredible value once new drugs are approved, investor interest in the field of biotechnology is running high.

Read full article... Read full article...

 


Companies

Wednesday, April 17, 2019

Elliott Wave Analysis of XBI (Biotech ETF) / Companies / BioTech

By: WavePatternTraders

This is one area of the market that is actually showing some weakness compared to the NDX and SPX, so it could be a warning for both those markets. The reversal from the last minor swing high at $93.87 could be favoring a peak in place, although I would still allow for a bit more upside to end wave [B] if needed.

As long as it fails to make a new high above $101.52, then it has a bearish setup for a move lower and tests $60.00 - 55.00 to end wave [C] to complete a large 3 wave decline from $101.52.

Bearish below $101.52, but tentatively looking lower below $93.87.
Read full article... Read full article...

 


Companies

Monday, April 08, 2019

5 Biotech Stocks That You Should Be Watching Right Now! / Companies / BioTech

By: Submissions

The world of biotechnology is changing rapidly. Today, there are more answers for medical questions than ever before. However, that doesn’t mean that innovation is coming to an end. Several companies dedicate their efforts to finding solutions for some of the world’s most debilitating conditions.

This medical innovation has led to droves of investor interest. As more and more companies find solutions, more and more investors are finding profits. However, as with any investment, investing in the biotechnology space can come with risk.

Read full article... Read full article...

 


Companies

Friday, November 23, 2018

DNA Breakthrough: Scientists Repair Genes in Human Embryos / Companies / BioTech

By: Andrew_Cioffi

The medical field is set to change tremendously owing to a recent breakthrough by medical researchers. A team of researchers recently managed to use gene-editing tools to remove mutations in embryos which develop into human diseases. The team that comprised of the Oregon Health and Science University and other researchers were able to make breakthrough discoveries. The particular disease, hypertrophic cardiomyopathy, is passed down genetically and is a cause of many deaths especially among young athletes. It is not clear yet as to when the technology will be applied in the real world.

Read full article... Read full article...

 


Companies

Thursday, May 03, 2018

4 Biotech Stock Movers to Watch / Companies / BioTech

By: Harry_Boxer

Biotechs continue to dominate our list of top charts to watch.

CASI Pharmaceuticals Inc. (CASI) rose 48 cents, or 7.2%, to $7.14 on 773,700 shares Tuesday. The move came on no news, although the stock soared in early April on news that China's Food and Drug Administration (CFDA) would convene a panel to discuss its cancer therapy, Evomela. The stock has been flagging since that move, but may be positioning to break out, with the next target at $10.

Read full article... Read full article...

 


Companies

Monday, September 11, 2017

Could This Be The Biggest Biotech Breakthrough Of The Year? / Companies / BioTech

By: OilPrice_Com

Someone dies of a stroke every 4 minutes in the United States. Globally, 15 million people suffer a stroke every year. It’s debilitating physically and financially—but one little-known company has developed a medical device that hopes to challenge that deadly statistic.

It’s been quietly developing this new technology for 10 years. Now it’s released updated preliminary clinical trial results, and signed a manufacturing deal which could make a significant impact in the medical device industry.

After a decade of painstaking development, we’re now nearing the end of the long road to validation, and for investors who understand this industry, this could be the critical juncture.

Read full article... Read full article...

 


Companies

Wednesday, July 19, 2017

Biotech with Alzheimer's Focus Makes Progress on Several Fronts / Companies / BioTech

By: TLSReport

In its corporate update for Q2/17, a Canada-based biotech targeting neurological disorders including Alzheimer's disease informed investors of advancements in several programs, including designation of a second validated lead compound in development.

Among ProMIS Neurosciences Inc.'s (PMN:TSE) "key accomplishments" in the quarter, the company noted it expanded its potentially "best in class amyloid-beta (Aβ) portfolio for Alzheimer's disease," according to a July 10 news release. In its oral presentation, the company stressed its emphasis on the "best in class" goal, noting that even though Biogen Inc.'s (BIIB:NASDAQ) aducanumab will be "first in class" and is progressing well in development, the ProMIS compound could be more selective and possess greater patient benefits.

Read full article... Read full article...

 


Page << | 1 | 2 | 3 | 4 | >>